FBRX logo

Forte Biosciences, Inc. Stock Price

NasdaqCM:FBRX Community·US$586.1m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 2 Fair Values set on narratives written by author

FBRX Share Price Performance

US$20.97
13.47 (179.60%)
US$20.97
13.47 (179.60%)
Price US$20.97

FBRX Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with moderate risk.

5 Risks
1 Reward

Forte Biosciences, Inc. Key Details

US$0

Revenue

US$0

Cost of Revenue

US$0

Gross Profit

US$75.9m

Other Expenses

-US$75.9m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
-2.99
0%
0%
0%
View Full Analysis

About FBRX

Founded
n/a
Employees
19
CEO
Paul A. Wagner
WebsiteView website
www.fortebiorx.com

Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company’s lead product candidate is the FB-102, a proprietary anti-CD122 monoclonal antibody therapeutic candidate for various autoimmune and autoimmune-related indications, such as celiac disease, vitiligo, alopecia areata, and type 1 diabetes. Forte Biosciences, Inc. is headquartered in Dallas, Texas.

Recent FBRX News & Updates

Recent updates

No updates